iBio (IBIO) News Today

iBio logo
$0.75 +0.04 (+5.86%)
Closing price 11/17/2026 04:00 PM Eastern
Extended Trading
$0.74 -0.01 (-1.35%)
As of 04:43 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Why Is iBio Up Today?

iBio, Inc. (NASDAQ: IBIO) disclosed encouraging early-stage data for its obesity and cardiometabolic drug programs, while HC Wainwright lowered several future earnings estimates. The pipeline news may support investor optimism, but the estimates point to continued expected losses.

  • Positive Sentiment: iBio reported that its experimental obesity antibody IBIO-610 produced a 2.3% vehicle-adjusted body-weight difference in obese non-human primates at 28 weeks. The study also found lower body-fat measures while generally maintaining lean mass, alongside sustained Activin E suppression. iBio Announces New Preclinical Data Across Obesity and Cardiometabolic Portfolio at Multiple Scientific Conferences
  • Positive Sentiment: The company also reported that an experimental amylin-receptor candidate selectively activated targeted receptors in laboratory tests and reduced food intake in rats. iBio plans further preclinical studies, with additional data presentations scheduled.
  • Neutral Sentiment: Both programs remain preclinical, so the findings do not establish that the therapies will be safe or effective in people. The reported weight result was modest, and further development and clinical testing will be needed.
  • Negative Sentiment: HC Wainwright cut its projected EPS for Q2–Q4 2027 and fiscal 2027–2030, citing larger expected losses; for example, its FY2027 estimate moved to a loss of $0.38 per share from $0.30, and its FY2030 estimate to a loss of $0.78 from $0.57. The firm nevertheless maintained its Buy rating and $7 price target.
Posted 9h agoAI Generated. May Contain Errors.

iBio Latest News

HC Wainwright Issues Pessimistic Estimate for iBio Earnings
Brookline Capital Markets Boosts Earnings Estimates for iBio
iBio (IBIO) Set to Announce Quarterly Earnings on Wednesday
iBio (IBIO) Projected to Announce Earnings on Wednesday
iBio to Participate in Upcoming Investor Conferences
Could iBio (IBIO) Be an Underrated Obesity Stock?
5 Under-the-Radar AI Stocks to Buy in 2026
iBio Strengthens Board with Appointment of Dr. Stoner
iBio, Inc. Common Stock (IBIO)
Ibio (IBIO) Receives a Buy from Chardan Capital

iBio Media Mentions By Week

iBio Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IBIO
News Sentiment
▼
0.29

0.56
▲
Average
Healthcare
News Sentiment

iBio News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IBIO Articles
This Week
▼
19

3
▲
IBIO Articles
Average Week

iBio Trends on MarketBeat

This week vs. last week
New Followers
1
Searches
1
-80%
Page Views
952
-17%
Get iBio News Delivered to You Automatically

Sign up to receive the latest news and ratings for IBIO and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for iBio dated 11/17/2026.
From Our Partners